Systemic Tofacitinib in Alopecia Areata: A Single Center Retrospective Descriptive Cohort Study

    January 2024 in “ Arab Board Medical Journal ”
    Ameera S. Al Ali, Yusra S. Al Ali, Raghda S. Al Maashari
    Studysummary This study found that tofacitinib was an effective and well-tolerated treatment for alopecia areata, with significant to moderate hair regrowth in 78% of patients observed.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 9

    1. Prognostic Factors in Mexican Patients with Patchy and Other Types of Alopecia Areata Skin appendage disorders · 2020
    2. Alopecia Areata: A Multifactorial Autoimmune Condition Journal of autoimmunity · 2018
    3. Oral Tofacitinib Monotherapy in Korean Patients with Refractory Moderate-to-Severe Alopecia Areata: A Case Series Journal of the American Academy of Dermatology · 2017
    4. Tofacitinib for the Treatment of Severe Alopecia Areata and Variants: A Study of 90 Patients Journal of The American Academy of Dermatology · 2016
    5. Safety and Efficacy of the JAK Inhibitor Tofacitinib Citrate in Patients with Alopecia Areata JCI insight · 2016
    6. Development of Uniform Protocol for Alopecia Areata Clinical Trials Journal of Investigative Dermatology Symposium Proceedings · 2015
    7. Alopecia Areata Is Driven by Cytotoxic T Lymphocytes and Is Reversed by JAK Inhibition Nature medicine · 2014
    8. Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis Journal of Investigative Dermatology · 2014
    9. Alopecia Areata: An Update Indian Journal of Dermatology, Venereology and Leprology · 2013